Effect of ginseng polysaccharides and dendritic cells on the balance of Th1/Th2T helper cells in patients with non-small cell lung cancer

Journal of Traditional Chinese Medicine

Volumn 34, Issue 6, 2014, Pages 641-645

  Ma, Junjie ^a   Liu, Huiping ^b,c   Wang, Xiaolong ^d  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c THE AFFILIATED BENQ HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^d the People's Hospital of Shu yang   (China)

Author keywords

Carcinoma; Dendritic cells; Interferons; Interleukins; Non small cell lung; Panax

Indexed keywords

GAMMA INTERFERON; GINSENG POLYSACCHARIDE; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; CYTOKINE; HERBACEOUS AGENT; POLYSACCHARIDE;

ADULT; AGED; ARTICLE; CELL THERAPY; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL ASSESSMENT OF CANCER TREATMENT LUNG QUESTIONNAIRE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; PROTEIN EXPRESSION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TH1 CELL; TH2 CELL; TREATMENT OUTCOME; BIOLOGICAL THERAPY; CARCINOMA, NON-SMALL-CELL LUNG; CHEMISTRY; GENETICS; IMMUNOLOGY; LUNG NEOPLASMS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PANAX; TRANSPLANTATION;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CELL- AND TISSUE-BASED THERAPY; COMBINED MODALITY THERAPY; CYTOKINES; DENDRITIC CELLS; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PANAX; POLYSACCHARIDES; QUALITY OF LIFE; TH1 CELLS; TH2 CELLS;

EID: 84925230357     PISSN: 02552922     EISSN: 2589451X     Source Type: Journal    
DOI: 10.1016/s0254-6272(15)30076-5     Document Type: Article

References (17)

1. Bunn PA Jr, Thatcher N. Systemic treatment for advanced (stage III b/IV) non-small cell lung cancer: more treatment options; more things to consider. Conclusion Oncologist 2008; 13(SUPPL. 1): 37-46.
2. Panoskaltsis N, Reid CCL, Knight SC. Immune modulation with dendritic cells. Transfus Med 2004; 14(2): 81-96.
3. Fong L, Brockstedt D, Benike C., Wu L, Engleman EG. Dendritic cells injected via different routes induce immunity in cancer patients. J Immunol 2001; 166(6): 4254-4259.
4. Shaw JP, Dembitzer FR, Wisnivesky J.P., et al. Vidio-assisted thoracoscopic lobectomy: state of the art and future directions. Ann Thorac Surg 2008; 85(2): 705-709.
5. Kim MH, Byon YY, Ko E.J., et al. Immunomodulatory activity of ginsan, a polysaccharide of Renshen (Radix Ginseng), on dendritic cells. Koraen J Physiol Pharmacol 2009; 13(3): 169-173.
6. Adurthi S, Mukherjee G, Krishnamurthy H., et al. Functional tumor infiltrating TH1 and TH2 effectors in large early-stage cervical cancer are suppressed by regulatory T cells. Int J Gynecol Cancer 2012; 22(7): 1130-1137.
7. Eftimie R, Bramson JL, Earn DJ. Modeling anti-tumor Th1 and Th2 immunity in the rejection of melanoma. J Theor Biol 2010; 265(3): 467-480.
8. Travis WD, Brambilla E, Muller-Hermelink HK, et al. WHO Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press, 2004: 26-67.
9. Edge SB, Compton CC. The American Joint Committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010; 17 (6): 1471-1474.
10. Hirschowitz EA, Foody T, Hidalgo G.E., Yannelli JR. Immunization of NSCLC patients with antigenpulsed immature autologous dendritic cells. Lung Cancer 2007; 57 (3): 365-372.
11. Hong S, Qian J, Yang J., Li H, Kwak LW, Yi Q. Roles of idiotype-specific t cells in myeloma cell growth and survival: Th1 and CTL cells are tumoricidal while Th2 cells promote tumor growth. Cancer Res 2008; 68(20): 8456-8464.
12. Chechlinska M, Duma A, Swierkowska K., Kamińska J, Steffen J. Sera of lung cancer patients affect the release of Th1, Th2 and monocyte-derived cytokines, and the expression of IL-2R alpha by normal, stimulated mononuclear cells. Cell Mol Biol Lett 2004; 9(1): 69-81.
13. Dillman R, Selvan S, Schiltz P., et al. Phase I/II trial of melanoma patient-specific vaccine of proliferating autolo-gous tumor cells, dendritic cells, and GM-CSF: planned interim analysis. Cancer Biother Radiopharm 2004; 19(5): 658-665.
14. Palucka AK, Dhodapkar MV, Paczesny S, Ueno H., Fay J, Banchereau J. Boosting vaccinations with pep-tide-pulsed CD34+ progenitor-derived dendritic cells can expand long-lived melanoma peptide-specific CD8 + T cells in patients with metastatic melanoma. J Immunother 2005; 28(2): 158-168.
15. Wan H, Dupasquier M. Dendritic cells in vivo and in vitro. Cell Mol Immunol 2005; 2(1): 28-35.
16. Block MS, Nevala WK, Leontovich A.A., Markovic SN. Differential response of human and mouse dendritic cells to VEGF determines interspecies discrepancies in tumormediated TH1/TH2 polarity shift. Clin Cancer Res 2011; 17(7): 1776-1783.
17. Cheng H, Li S, Fan Y., et al. Comparative studies of the antiproliferative effects of ginseng polysaccharides on HT-29 human colon cancer cells. Med Oncol 2011; 28 (1): 175-181.